James Maxwell

James Maxwell currently serves as the Chief Financial Officer at Bioscript Group, a position held since September 2023. Prior to this role, James Maxwell was the Chief Financial Officer at Panthera Biopartners from September 2022 to September 2023. Earlier in their career, James Maxwell held the position of Managing Director and Chief Operating Officer at CHS Healthcare from February 2018 to September 2022. James Maxwell's experience at KPMG spanned from September 2008 to February 2018, where James Maxwell progressed from an Associate in KPMG Corporate Finance to an Associate Director.